CHE
Chemed CorpTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-09 | LINDELL ANDREA R |
Director |
Sell↓
|
Capital Stock
|
1,347 |
| 2026-05-29 | WALSH GEORGE J III |
Director |
Sell↓
|
Capital Stock
|
500 |
| 2026-05-18 | WALSH GEORGE J III |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-18 | DeLyons Ron |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-18 | GRACE PATRICK P |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-18 | Mount John Meredith Jr. |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-18 | McCarthy Eileen P |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-18 | LINDELL ANDREA R |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-18 | Heaney Christopher J |
Director |
Award↑
Filing footnotes — Capital Stock (Direct)
Award of stock |
Capital Stock
|
386 |
| 2026-05-08 | GRACE PATRICK P |
Director |
Sell↓
|
Capital Stock
|
60 |
| 2026-05-01 | MCNAMARA KEVIN J |
Director, president and CEO |
Sell↓
Filing footnotes — Capital Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $418.99 to $424.95. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Capital Stock
|
2,000 |
| 2026-03-27 | MCNAMARA KEVIN J |
Director, president and CEO |
Sell↓
Filing footnotes — Capital Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.76 to $373.24. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Capital Stock
|
1,500 |
| 2026-03-12 | MCNAMARA KEVIN J |
Director, president and CEO |
Sell↓
Filing footnotes — Capital Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.31 to $404.68. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Capital Stock
|
2,000 |
| 2026-02-13 | MCNAMARA KEVIN J |
Director, president and CEO |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
2,187 |
| 2026-02-13 | MCNAMARA KEVIN J |
Director, president and CEO |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. |
Capital Stock
|
2,714 |
| 2026-02-13 | Wherley Joel L |
CEO - Vitas Healthcare |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
220 |
| 2026-02-13 | Judkins Brian C |
VP and Chief Legal Officer |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. |
Capital Stock
|
0 |
| 2026-02-13 | Judkins Brian C |
VP and Chief Legal Officer |
Award↑
Filing footnotes — Performance Stock Units (Direct)
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. |
Performance Stock Units
|
908 |
| 2026-02-13 | HUTTON THOMAS C |
Director, vice president |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
160 |
| 2026-02-13 | Witzeman Michael D |
VP & Chief Financial Officer |
Tax↓
Filing footnotes — Capital Stock (Direct)
Shares withheld to satisfy tax obligations in connection with vesting of PSUs. |
Capital Stock
|
120 |
| 2026-02-13 | MCNAMARA KEVIN J |
Director, president and CEO |
Award↑
Filing footnotes — Performance Stock Units (Direct)
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. |
Performance Stock Units
|
5,114 |
| 2026-02-13 | Witzeman Michael D |
VP & Chief Financial Officer |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
333 |
| 2026-02-13 | Wherley Joel L |
CEO - Vitas Healthcare |
Tax↓
Filing footnotes — Capital Stock (Direct)
Shares withheld to satisfy tax obligations in connection with vesting of PSUs. |
Capital Stock
|
80 |
| 2026-02-13 | LEE SPENCER S |
executive vice president |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
402 |
| 2026-02-13 | LEE SPENCER S |
executive vice president |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. |
Capital Stock
|
499 |
| 2026-02-13 | Wherley Joel L |
CEO - Vitas Healthcare |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
220 |
| 2026-02-13 | HUTTON THOMAS C |
Director, vice president |
Tax↓
Filing footnotes — Capital Stock (Direct)
Shares withheld to satisfy tax obligations in connection with vesting of PSUs. |
Capital Stock
|
72 |
| 2026-02-13 | MCNAMARA KEVIN J |
Director, president and CEO |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
2,187 |
| 2026-02-13 | Wherley Joel L |
CEO - Vitas Healthcare |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. |
Capital Stock
|
0 |
| 2026-02-13 | LEE SPENCER S |
executive vice president |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. |
Capital Stock
|
0 |
| 2026-02-13 | Judkins Brian C |
VP and Chief Legal Officer |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
283 |
| 2026-02-13 | LEE SPENCER S |
executive vice president |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
402 |
| 2026-02-13 | MCNAMARA KEVIN J |
Director, president and CEO |
Tax↓
Filing footnotes — Capital Stock (Direct)
Shares withheld to satisfy tax obligations in connection with vesting of PSUs. |
Capital Stock
|
1,192 |
| 2026-02-13 | Judkins Brian C |
VP and Chief Legal Officer |
Tax↓
Filing footnotes — Capital Stock (Direct)
Shares withheld to satisfy tax obligations in connection with vesting of PSUs. |
Capital Stock
|
102 |
| 2026-02-13 | Witzeman Michael D |
VP & Chief Financial Officer |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
333 |
| 2026-02-13 | Witzeman Michael D |
VP & Chief Financial Officer |
Award↑
Filing footnotes — Performance Stock Units (Direct)
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. |
Performance Stock Units
|
1,394 |
| 2026-02-13 | HUTTON THOMAS C |
Director, vice president |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
160 |
| 2026-02-13 | Witzeman Michael D |
VP & Chief Financial Officer |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. |
Capital Stock
|
413 |
| 2026-02-13 | Judkins Brian C |
VP and Chief Legal Officer |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. |
Capital Stock
|
351 |
| 2026-02-13 | LEE SPENCER S |
executive vice president |
Award↑
Filing footnotes — Performance Stock Units (Direct)
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. |
Performance Stock Units
|
960 |
| 2026-02-13 | HUTTON THOMAS C |
Director, vice president |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. |
Capital Stock
|
0 |
| 2026-02-13 | LEE SPENCER S |
executive vice president |
Tax↓
Filing footnotes — Capital Stock (Direct)
Shares withheld to satisfy tax obligations in connection with vesting of PSUs. |
Capital Stock
|
154 |
| 2026-02-13 | Witzeman Michael D |
VP & Chief Financial Officer |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. |
Capital Stock
|
0 |
| 2026-02-13 | HUTTON THOMAS C |
Director, vice president |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Administrative error from 8/7/24 filing; previous holdings were ouverstated by 673 shares |
Capital Stock
|
199 |
| 2026-02-13 | Judkins Brian C |
VP and Chief Legal Officer |
Convert↓
Filing footnotes — Performance Stock Units (Direct)
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. |
Performance Stock Units
|
283 |
| 2026-02-13 | Wherley Joel L |
CEO - Vitas Healthcare |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. |
Capital Stock
|
273 |
| 2026-02-13 | Wherley Joel L |
CEO - Vitas Healthcare |
Award↑
Filing footnotes — Performance Stock Units (Direct)
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. |
Performance Stock Units
|
1,142 |
| 2026-02-13 | MCNAMARA KEVIN J |
Director, president and CEO |
Convert↑
Filing footnotes — Capital Stock (Direct)
The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. |
Capital Stock
|
0 |
| 2026-02-13 | HUTTON THOMAS C |
Director, vice president |
Award↑
Filing footnotes — Performance Stock Units (Direct)
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. |
Performance Stock Units
|
374 |
| 2025-12-26 | LINDELL ANDREA R |
Director |
Gift↓
|
Capital Stock
|
463 |